Federal Supply Schedule 36F79721D0252
Award Date
9/15/21
Last Date to Order
9/14/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Urovant Sciences Inc.
Ultimate Awardee
Sumitovant Biopharma, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Omeros Corporation under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for $18.91 million through March 1, 2023. The contract provides access to 65 I B products through established price lists. As a pharmaceutical supply contract...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Vivus LLC, is for the procurement of pharmaceutical and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $5,316,660.00 and a period of performance through April 30, 2025. As a multiple award schedule, this contract allows the VA and other authorized federal agencies to purchase a variety of pharmaceutical and hematology products from Vivus LLC. The scope...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides Pharmaceuticals and Drugs (FSS-61-IB) to the agency's Veterans Integrated Service Network 12. The prime contractor, Avion Pharmaceuticals, LLC, was awarded this multiple-award contract with a ceiling value of $675,000.00 and a period of performance through December 31, 2025. The contracted products and services encompass a broad range of pharmaceutical and hematology-related items....
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 has awarded Revance Therapeutics, Inc., a for-profit organization, an Interim Agreement under Federal Supply Schedule (FSS) 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. This is a Multiple Award contract with a potential value of $25,000.00 and a period of performance running through May 14, 2024. The contract aims to procure pharmaceutical products and related services....
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Aytu Biopharma Inc. for pharmaceuticals and drugs under GSA Schedule 65 IB. With a potential value of $2,942,740 and a period of performance through August 1, 2023, this multiple-award contract provides various pharmaceutical products and hematology-related items to VA medical facilities. The original solicitation sought drugs,...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Ulai Health LLC, covers the procurement of drugs, pharmaceuticals, and hematology-related products. As a multiple-award GSA schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) category, it allows the VA to streamline the ordering of these medical items through pre-negotiated terms and pricing. The contract, which has a ceiling value of $2.25 million and a period of performance...